These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. In Silico Trial of MR-Guided Midtreatment Adaptive Planning for Hypofractionated Stereotactic Radiation Therapy in Centrally Located Thoracic Tumors. Henke LE; Kashani R; Hilliard J; DeWees TA; Curcuru A; Przybysz D; Green O; Robinson CG; Bradley JD Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):987-995. PubMed ID: 29953910 [TBL] [Abstract][Full Text] [Related]
11. Role of Daily Plan Adaptation in MR-Guided Stereotactic Ablative Radiation Therapy for Adrenal Metastases. Palacios MA; Bohoudi O; Bruynzeel AME; van Sörsen de Koste JR; Cobussen P; Slotman BJ; Lagerwaard FJ; Senan S Int J Radiat Oncol Biol Phys; 2018 Oct; 102(2):426-433. PubMed ID: 29902559 [TBL] [Abstract][Full Text] [Related]
12. Accelerated Hypofractionated Radiotherapy Versus Stereotactic Body Radiotherapy for the Treatment of Stage I Nonsmall Cell Lung Cancer-A Single Institution Experience With Long-Term Follow-Up. Karasawa K; Hayakawa S; Machitori Y; Shibata Y; Ogawa H; Ito K; Shimizuguchi T; Kawamoto T; Nihei K Technol Cancer Res Treat; 2018 Jan; 17():1533033818806318. PubMed ID: 30317929 [TBL] [Abstract][Full Text] [Related]
13. To fly or not to fly: Stereotactic MR-guided adaptive radiotherapy effectively treats ultracentral lung tumors with favorable long-term outcomes. Regnery S; Katsigiannopulos E; Hoegen P; Weykamp F; Sandrini E; Held T; Deng M; Eichkorn T; Buchele C; Rippke C; Renkamp CK; König L; Lang K; Thomas M; Winter H; Adeberg S; Klüter S; Debus J; Hörner-Rieber J Lung Cancer; 2023 May; 179():107175. PubMed ID: 36965207 [TBL] [Abstract][Full Text] [Related]
14. Radical stereotactic radiosurgery with real-time tumor motion tracking in the treatment of small peripheral lung tumors. Collins BT; Erickson K; Reichner CA; Collins SP; Gagnon GJ; Dieterich S; McRae DA; Zhang Y; Yousefi S; Levy E; Chang T; Jamis-Dow C; Banovac F; Anderson ED Radiat Oncol; 2007 Oct; 2():39. PubMed ID: 17953752 [TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes of stereotactic magnetic resonance image-guided adaptive radiotherapy for primary and metastatic tumors in the abdomen and pelvis. Yoon SM; Luterstein E; Chu FI; Cao M; Lamb J; Agazaryan N; Low D; Raldow A; Steinberg ML; Lee P Cancer Med; 2021 Sep; 10(17):5897-5906. PubMed ID: 34288538 [TBL] [Abstract][Full Text] [Related]
16. Safety and Efficacy of Stereotactic Ablative Radiation Therapy for Renal Cell Carcinoma Extracranial Metastases. Wang CJ; Christie A; Lin MH; Jung M; Weix D; Huelsmann L; Kuhn K; Meyer J; Desai N; Kim DWN; Pedrosa I; Margulis V; Cadeddu J; Sagalowsky A; Gahan J; Laine A; Xie XJ; Choy H; Brugarolas J; Timmerman R; Hannan R Int J Radiat Oncol Biol Phys; 2017 May; 98(1):91-100. PubMed ID: 28587057 [TBL] [Abstract][Full Text] [Related]
17. Dosimetric Comparison of Real-Time MRI-Guided Tri-Cobalt-60 Versus Linear Accelerator-Based Stereotactic Body Radiation Therapy Lung Cancer Plans. Wojcieszynski AP; Hill PM; Rosenberg SA; Hullett CR; Labby ZE; Paliwal B; Geurts MW; Bayliss RA; Bayouth JE; Harari PM; Bassetti MF; Baschnagel AM Technol Cancer Res Treat; 2017 Jun; 16(3):366-372. PubMed ID: 28168936 [TBL] [Abstract][Full Text] [Related]
18. Repeat stereotactic body radiation therapy for patients with pulmonary malignancies who had previously received SBRT to the same or an adjacent tumor site. Valakh V; Miyamoto C; Micaily B; Chan P; Neicu T; Li S J Cancer Res Ther; 2013; 9(4):680-5. PubMed ID: 24518717 [TBL] [Abstract][Full Text] [Related]
19. Phase I trial of stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of oligometastatic or unresectable primary malignancies of the abdomen. Henke L; Kashani R; Robinson C; Curcuru A; DeWees T; Bradley J; Green O; Michalski J; Mutic S; Parikh P; Olsen J Radiother Oncol; 2018 Mar; 126(3):519-526. PubMed ID: 29277446 [TBL] [Abstract][Full Text] [Related]
20. Outcomes of single fraction stereotactic ablative radiotherapy for lung metastases. Filippi AR; Badellino S; Guarneri A; Levis M; Botticella A; Mantovani C; Ragona R; Racca P; Buffoni L; Novello S; Ricardi U Technol Cancer Res Treat; 2014 Feb; 13(1):37-45. PubMed ID: 23819496 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]